1,018
Participants
Start Date
April 1, 2006
Primary Completion Date
October 1, 2006
Study Completion Date
October 1, 2006
Pramipexole
Boehringer Ingelheim Investigational Site, Vienna
Boehringer Ingelheim Investigational Site, Vienna
Hopital Cantonal (HUG), Geneva
Boehringer Ingelheim Investigational Site, Innsbruck
Clinica Hildebrand, Brissago
Kantonsspital St. Gallen, Sankt Gallen
Hospital Puerta del Mar. Neurology, Cadiz
Neurologisches Fachkrankenhaus fur, Beelitz-Heilstätten
Azienda Ospedaliera S. Martino, Genova
Hopital Rangueil, Toulouse
Hopital Purpan, Toulouse
Gertrudis-Kliniken Biskirchen, Leun
Hospital de Cruces. Neurology, Baracaldo / Bilbao
Parkinson Klinik Wolfach, Wolfach
Universita Federico II, Napoli
Boehringer Ingelheim Investigational Site, Unterhaching
Policlinico di Catania, Catania
Universitatsklinikum Carl Gustav Carus Dresden, Dresden
Boehringer Ingelheim Investigational Site, Gera
Universita La Sapienza di Roma, Roma
Academisch Ziekenhuis Maastricht, Maastricht
Hospital Clinic i Provincial. Neurology, Barcelona
Boehringer Ingelheim Investigational Site, London
Boehringer Ingelheim Investigational Site, Newark
Lead Sponsor
Boehringer Ingelheim
INDUSTRY